Ibrance: tough pill to swallow for two Rotorua women fighting for lives

New Zealand Herald

26 January 2019 - One Rotorua woman has had to sell her rental property to pay the thousands of dollars needed monthly for breast cancer treatment, Ibrance.

The parents of another cancer sufferer have had to give up their retirement savings to cover the cost of the unsubsidised drug.

Both women have stage 4 metastatic breast cancer and are part of a national support network of Metavivors, secondary breast cancer sufferers, fighting to have the drug, which they say is extending their lives, subsidised.

Read New Zealand Herald article 

Michael Wonder

Posted by:

Michael Wonder